LEADER 01548nam  2200373   450 
001 9910688600803321
005 20230623194921.0
024 7 $a10.5772/intechopen.87599
035   $a(CKB)5400000000042198
035   $a(NjHacI)995400000000042198
035   $a(EXLCZ)995400000000042198
100   $a20230623d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMultiple Myeloma /$fedited by Ota Fuchs
210  1$aLondon, England :$cIntechOpen,$d2021.
215   $a1 online resource (126 pages)
311   $a1-83968-622-7 
330   $aThis book deals with the diagnosis and treatment of multiple myeloma. Multiple myeloma is a plasma cell disorder, the prognosis of which has dramatically improved in the last years thanks to new immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, in relapsed/refractory disease and a diagnosis. Chapters cover such topics as prognostic and predictive factors in newly diagnosed multiple myeloma, treatment approaches, antibody therapies, and three-dimensional (3D) models mimicking multiple myeloma bone marrow-microenvironment interactions.
606   $aBones$xCancer
606   $aBones$xTumors
615  0$aBones$xCancer.
615  0$aBones$xTumors.
676   $a616.99471
702   $aFuchs$b Ota
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688600803321
996   $aMultiple Myeloma$91522185
997   $aUNINA